Chiesi Group
Katiuscia Dallaglio is an accomplished R&D Project Leader at Chiesi Group, specializing in Advanced Therapies for Rare Diseases since April 2017, with prior experience as an R&D Preclinical Scientist in the same field. Katiuscia has a substantial research background, including a post-doctoral fellowship focused on human melanoma stem cells at Translational Research Lab. Arcispedale Santa Maria Nuova IRCCS, and previous roles as a Research Collaborator and Scientist at various institutions, concentrating on topics such as chemoprevention, tumor microenvironments, and apoptosis in skin cancer. Katiuscia's educational credentials include a Clinical Pathology degree and a Ph.D. in Molecular Medicine and Regenerative Medicine from Università degli Studi di Modena e Reggio Emilia, complemented by a Master’s and Bachelor's degree in Biotechnology from the same university.
This person is not in any teams
This person is not in any offices
Chiesi Group
15 followers
Chiesi is an international company originated in Parma, with 85 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas